Frontiers in Pharmacology,
Journal Year:
2025,
Volume and Issue:
16
Published: Feb. 18, 2025
Owing
to
its
high
mortality
rate,
lung
cancer
(LC)
remains
the
most
common
worldwide,
with
highest
malignancy
diagnosis
rate.
The
phosphatidylinositol-3-kinase
(PI3K)/protein
kinase
B
(AKT)/mammalian
target
of
rapamycin
(mTOR)
signaling
(PAM)
pathway
is
a
critical
intracellular
involved
in
various
cellular
functions
and
regulates
numerous
processes,
including
growth,
survival,
proliferation,
metabolism,
apoptosis,
invasion,
angiogenesis.
This
review
aims
highlight
preclinical
clinical
studies
focusing
on
PAM
LC
underscore
potential
natural
products
targeting
it.
Additionally,
this
synthesizes
existing
literature
discusses
combination
therapy
future
directions
for
treatment
while
acknowledging
ongoing
challenges
field.
Continuous
development
novel
therapeutic
agents,
technologies,
precision
medicine
offers
an
increasingly
optimistic
outlook
LC.
International Journal of Molecular Sciences,
Journal Year:
2023,
Volume and Issue:
24(2), P. 1422 - 1422
Published: Jan. 11, 2023
Excess
body
weight
is
frequently
associated
with
low-grade
inflammation.
Evidence
indicates
a
relationship
between
obesity
and
cancer,
as
well
other
diseases,
such
diabetes
non-alcoholic
fatty
liver
disease,
in
which
inflammation
the
actions
of
various
adipokines
play
role
pathological
mechanisms
involved
these
disorders.
Leptin
mainly
produced
by
adipose
tissue
proportion
to
fat
stores,
but
it
also
synthesized
organs,
where
leptin
receptors
are
expressed.
This
hormone
performs
numerous
brain,
related
control
energy
homeostasis.
It
neurogenesis
neuroprotection,
central
resistance
some
neurological
disorders,
e.g.,
Parkinson’s
Alzheimer’s
diseases.
In
peripheral
tissues,
implicated
regulation
metabolism,
bone
density
muscle
mass.
All
can
be
affected
changes
levels
this
hormone.
review
will
present
recent
advances
molecular
action
their
underlying
roles
situations,
may
interest
for
revealing
new
approaches
treatment
diseases
adipokine
might
compromised.
The EPMA Journal,
Journal Year:
2024,
Volume and Issue:
15(1), P. 1 - 23
Published: Feb. 27, 2024
Worldwide
stroke
is
the
second
leading
cause
of
death
and
third
disability
combined.
The
estimated
global
economic
burden
by
over
US$891
billion
per
year.
Within
three
decades
(1990-2019),
incidence
increased
70%,
deaths
43%,
prevalence
102%,
DALYs
143%.
Of
100
million
people
affected
stroke,
about
76%
are
ischemic
(IS)
patients
recorded
worldwide.
Contextually,
moves
into
particular
focus
multi-professional
groups
including
researchers,
healthcare
industry,
economists,
policy-makers.
Risk
factors
demonstrate
sufficient
space
for
cost-effective
prevention
interventions
in
primary
(suboptimal
health)
secondary
(clinically
manifested
collateral
disorders
contributing
to
risks)
care.
These
risks
interrelated.
For
example,
sedentary
lifestyle
toxic
environment
both
mitochondrial
stress,
systemic
low-grade
inflammation
accelerated
ageing;
inflammageing
a
associated
with
ageing
poor
outcomes.
Stress
overload,
decreased
bioenergetics
hypomagnesaemia
vasospasm
lesions
heart
brain
all
age
teenagers.
Imbalanced
dietary
patterns
folate
but
rich
red
processed
meat,
refined
grains,
sugary
beverages
hyperhomocysteinaemia,
inflammation,
small
vessel
disease,
IS
risks.
Ongoing
3PM
research
towards
vulnerable
population
promoted
European
Association
Predictive,
Preventive
Personalised
Medicine
(EPMA)
demonstrates
promising
results
holistic
patient-friendly
non-invasive
approach
utilising
tear
fluid-based
health
risk
assessment,
mitochondria
as
vital
biosensor
AI-based
data
interpretation
reported
here
EPMA
expert
group.
Collected
that
IS-relevant
corresponding
molecular
pathways
examples,
there
an
evident
overlap
between
involved
diabetic
retinopathy
early
indicator
patients.
Just
exemplify
some
them
such
5-aminolevulinic
acid/pathway,
which
also
characteristic
altered
mitophagy
patterns,
insomnia,
stress
regulation
modulation
microbiota-gut-brain
crosstalk.
Further,
ceramides
considered
mediators
oxidative
cardiometabolic
negatively
affecting
respiratory
chain
function
fission/fusion
activity,
sleep-wake
behaviour,
vascular
stiffness
remodelling.
Xanthine/pathway
homeostasis
stress-driven
anxiety-like
behaviour
well
mechanisms
arterial
stiffness.
In
order
assess
individual
risks,
application
machine
learning
(AI
tool)
essential
accurate
performed
multiparametric
analysis.
Aspects
presented
paper
include
needs
young
populations
elderly,
personalised
assessment
care,
cost-efficacy,
innovative
technologies
screening
programmes,
advanced
education
measures
professionals
general
population-all
pillars
paradigm
change
from
reactive
medical
services
overall
management
EPMA.
Frontiers in Endocrinology,
Journal Year:
2023,
Volume and Issue:
14
Published: Oct. 23, 2023
Forkhead
box
O
(FoxO)
proteins
are
transcription
factors
that
mediate
many
aspects
of
physiology
and
thus
have
been
targeted
as
therapeutics
for
several
diseases
including
metabolic
disorders
such
type
2
diabetes
mellitus
(T2D).
The
role
FoxO1
in
metabolism
has
well
studied,
but
recently
FoxO1’s
potential
prevention
therapy
debated.
For
example,
studies
shown
increased
activity
certain
tissue
types
contributes
to
T2D
pathology,
symptoms,
comorbidities,
yet
other
elevated
reported
alleviate
symptoms
associated
with
diabetes.
Furthermore,
opposite
effects
active
the
same
type.
liver,
by
increasing
hepatic
glucose
production.
However,
either
increase
or
decrease
lipogenesis
adipogenesis
white
adipose
tissue.
In
skeletal
muscle,
reduces
uptake
oxidation,
promotes
lipid
increases
muscle
atrophy.
While
show
lowers
pancreatic
insulin
production
secretion,
others
opposite,
especially
response
oxidative
stress
inflammation.
Elevated
hypothalamus
risk
developing
T2D.
may
mitigate
Alzheimer’s
disease,
a
neurodegenerative
disease
strongly
Conversely,
accumulating
evidence
implicates
Parkinson’s
pathogenesis.
Here
we
review
actions
conditions
tissues
abundantly
express
highlight
some
current
targeting
treatment.
World Journal of Diabetes,
Journal Year:
2024,
Volume and Issue:
15(7), P. 1430 - 1447
Published: July 8, 2024
Diabetes
mellitus
(DM)
and
Alzheimer's
disease
(AD)
are
two
major
health
concerns
that
have
seen
a
rising
prevalence
worldwide.
Recent
studies
indicated
possible
link
between
DM
an
increased
risk
of
developing
AD.
Insulin,
while
primarily
known
for
its
role
in
regulating
blood
sugar,
also
plays
vital
protecting
brain
functions.
Insulin
resistance
(IR),
especially
prevalent
type
2
diabetes,
is
believed
to
play
significant
AD's
development.
When
insulin
signalling
becomes
dysfunctional,
it
can
negatively
affect
various
functions,
making
individuals
more
susceptible
defining
features,
such
as
the
buildup
beta-amyloid
plaques
tau
protein
tangles.
Emerging
research
suggests
addressing
insulin-related
issues
might
help
reduce
or
even
reverse
changes
linked
This
review
aims
explore
rela-tionship
AD,
with
focus
on
IR.
It
explores
molecular
mechanisms
by
which
IR
lead
assesses
current
treatments
target
Understanding
IR's
connection
AD
offers
new
possibilities
highlights
importance
continued
this
interdisciplinary
field.
The EPMA Journal,
Journal Year:
2023,
Volume and Issue:
14(1), P. 43 - 51
Published: Feb. 22, 2023
Type
2
diabetes
(T2DM)
defined
as
the
adult-onset
type
that
is
primarily
not
insulin-dependent,
comprises
over
95%
of
all
mellitus
(DM)
cases.
According
to
global
records,
537
million
adults
aged
20-79
years
are
affected
by
DM
means
at
least
1
out
15
persons.
This
number
projected
grow
51%
year
2045.
One
most
common
complications
T2DM
diabetic
retinopathy
(DR)
with
an
overall
prevalence
30%.
The
total
DR-related
visual
impairments
on
rise,
due
growing
population.
Proliferative
(PDR)
progressing
DR
and
leading
cause
preventable
blindness
in
working-age
adults.
Moreover,
PDR
characteristic
systemic
attributes
including
mitochondrial
impairment,
increased
cell
death
chronic
inflammation,
independent
predictor
cascading
DM-complications
such
ischemic
stroke.
Therefore,
early
a
reliable
appearing
upstream
this
"domino
effect".
Global
screening,
timely
identification
DM-related
complications,
insufficiently
implemented
currently
applied
reactive
medicine.
A
personalised
predictive
approach
cost-effective
targeted
prevention
shortly
-
predictive,
preventive
medicine
(PPPM
/
3PM)
could
make
good
use
accumulated
knowledge,
preventing
other
severe
complications.
In
order
reach
goal,
stage-
disease-specific
biomarker
panels
needed
characterised
easy
way
sample
collection,
high
sensitivity
specificity
analyses.
current
study,
we
tested
hypothesis
non-invasively
collected
tear
fluid
robust
source
for
analysis
ocular
(DM-related
complications)
patterns
suitable
differential
diagnosis
stable
versus
PDR.
Here,
report
first
results
comprehensive
ongoing
which
correlate
individualised
patient
profiles
(healthy
controls
patients
D
well
without
co-morbidities)
their
metabolic
fluid.
Comparative
mass
spectrometric
performed
has
identified
following
clusters
differentially
expressed
groups
comparison:
acylcarnitines,
amino
acid
&
related
compounds,
bile
acids,
ceramides,
lysophosphatidyl-choline,
nucleobases
phosphatidyl-cholines,
triglycerides,
cholesterol
esters,
fatty
acids.
Our
preliminary
data
strongly
support
potential
clinical
utility
indicating
unique
signature
stages
progression.
pilot
study
creates
platform
validating
stratify
T2DM-patients
predisposed
since
T2DM-related
stroke,
our
international
project
aims
create
analytical
prototype
"diagnostic
tree"
(yes/no)
applicable
healthrisk
assessment
care.
Human Genomics,
Journal Year:
2024,
Volume and Issue:
18(1)
Published: Feb. 8, 2024
Abstract
Background
Diabetes
is
a
spectrum
of
metabolic
diseases
affecting
millions
people
worldwide.
The
loss
pancreatic
β-cell
mass
by
either
autoimmune
destruction
or
apoptosis,
in
type
1-diabetes
(T1D)
and
2-diabetes
(T2D),
respectively,
represents
pathophysiological
process
leading
to
insulin
deficiency.
Therefore,
therapeutic
strategies
focusing
on
restoring
secretory
capacity
may
impact
disease
management.
This
study
took
advantage
powerful
integrative
bioinformatic
tools
scrutinize
publicly
available
diabetes-associated
gene
expression
data
unveil
novel
potential
molecular
targets
associated
with
dysfunction.
Methods
A
comprehensive
literature
search
for
human
studies
alterations
the
pancreas
T1D
T2D
was
performed.
total
6
were
selected
extraction
analysis.
Pathway
enrichment
analyses
differentially
expressed
genes
(DEGs)
conducted,
together
protein–protein
interaction
networks
identification
transcription
factors
(TFs).
For
noncoding
RNAs,
microRNAs
(miRNAs)
long
RNAs
(lncRNAs),
which
exert
regulatory
activities
diabetes,
identifying
target
pathways
regulated
these
fundamental
establishing
robust
network.
Results
Comparisons
DEGs
among
showed
59
common
4
more
studies.
Besides
mRNA,
it
possible
identify
miRNA
lncRNA.
Among
top
(TFs),
HIPK2,
KLF5,
STAT1
STAT3
emerged
as
regulators
altered
expression.
Integrated
analysis
protein-coding
genes,
miRNAs,
lncRNAs
pointed
out
several
involved
metabolism,
cell
signaling,
immune
system,
adhesion,
interactions.
Interestingly,
GABAergic
synapse
pathway
only
all
datasets.
Conclusions
demonstrated
power
bioinformatics
scrutinizing
data,
thereby
revealing
like
pathway,
holds
promise
modulating
α-cells
transdifferentiation
into
β-cells.
Neurology,
Journal Year:
2024,
Volume and Issue:
102(7)
Published: March 19, 2024
Molecular
omics
studies
have
identified
proteins
related
to
cognitive
resilience
but
unrelated
Alzheimer
disease
and
disease-related
dementia
(AD/ADRD)
pathologies.
Posttranslational
modifications
of
with
glycans
can
modify
protein
function.
In
this
study,
we
glycopeptiforms
associated
resilience.